Global Transplant Diagnostic Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026
MarketResearch.biz delivers in-depth insights on the global transplant diagnostic market in its upcoming report titled, “Global Transplant Diagnostic Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global transplant diagnostic market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global transplant diagnostic market report has been segmented on the basis of technology, products and services, application, end users, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts (auto transplantation). Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.
Increasing investments into research and development (R&D) of organ transplant techniques and diagnostic equipment, coupled with ongoing technological advancements in visual equipment are major factors driving growth of the global transplant diagnostics market. In addition, increasing adoption of stem cell therapy in developed and in some developed economies is another factor expected to boost growth of the global transplant diagnostics market over the forecast period.
However, high costs associated with treatment and procurement of advanced equipment used for transplant procedures is a major factor restraining growth of the global transplant diagnostics market. Additionally, limited medical reimbursement for organ donation and transplant procedures is another major factor hampering growth of the global transplant diagnostic market over the forecast period.
Currently, the market in North America dominates the global transplant diagnostic market in revenue terms owing to growing awareness about transplants, well established medical infrastructure, and high adoption of advanced diagnostic techniques in the region. The market in Europe accounted for second-highest revenue share in the global transplant diagnostic market, due to high healthcare expenditure by governments of countries, and high disposable income, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing government initiatives for the improvement of healthcare facilities and growing awareness about organ donation in emerging economies in the region.
Global transplant diagnostic market segmentation:
- Molecular Assay
- PCR Based
- Sequencing Based
- Non-molecular Assay
By products and services:
- Reagents and Consumables
- Software and Services
- Research Applications
- Diagnostic Applications
- Infectious Disease Diagnostics
- Histocompatibility Testing
- Blood Profiling
By end users:
- Commercial Service Providers
- Hospitals and Transplant Centers
- Research Laboratories and Academic Institutes
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Molecular Assay
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Hoffmann La-Roche AG.
- Abbott Laboratories Inc.
- Qiagen N.V.
- Immucor Transplant Diagnostics Inc.
- Bio-rad Laboratories Inc.
- Affymetrix Inc.
- Omixon Ltd.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!